Stocks
Nilsine Partners Makes New Investment in Amgen
Nilsine Partners LLC has made a new investment in Amgen Inc. (NASDAQ:AMGN), acquiring 9,193 shares of the medical research company's stock in the second quarter.
The institutional investor purchased these shares at an approximate value of $3,329,000, according to its most recent Form 13F filing with the SEC.
This is not the only investment made by Nilsine Partners LLC; the firm has also acquired a new stake in Amgen worth about $258,000, as disclosed in a separate filing.